The Share price of Anupam Rasayan India Ltd. witnessed a surge of over 6% early in the day on February 14, 2025, after the company announced a significant supply agreement. The firm signed a Letter of Intent (LOI) with a leading US-based multinational corporation to supply a high-performance speciality chemical used in critical polymer applications.
The agreement spans 10 years, with projected cumulative sales of $195 million (₹1,697 crore). This long-term deal is expected to enhance the company’s revenue visibility and strengthen its global partnerships. The speciality chemical will be manufactured using Anupam Rasayan’s existing facilities, ensuring operational efficiency.
The company’s CEO, Gopal Agrawal, said “We are honoured to partner with a US multinational, a global pioneer in innovation and technology. This LOI underscores our capability to deliver advanced, tailor-made chemical solutions for Polymer applications such as defence and aeronautics. We have been working on the development of this product for the last three years, investing significant time in trials and validation to ensure its performance meets the highest industry standards. The speciality chemical we are supplying will play a pivotal role in enhancing performance and ensuring safety under the most challenging conditions. Furthermore, this collaboration enables us to diversify our portfolio into a strategic market segment, which we regard as a cornerstone of our growth strategy.”
Established in 1984, Anupam Rasayan is one of India’s leading custom synthesis and speciality chemical manufacturers. The company operates six manufacturing facilities in Gujarat with a total capacity of 30,000 MT. It serves 71 domestic and international customers, including 31 multinational corporations, across various industries such as agrochemicals, personal care, pharmaceuticals, and polymer additives.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 14, 2025, 2:50 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates